PubMed:10389937 / 1274-1463 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PubMed/sourceid/10389937","sourcedb":"PubMed","sourceid":"10389937","source_url":"http://www.ncbi.nlm.nih.gov/pubmed/10389937","text":"MYCN-amplified tumors expressed lower levels of EPHB6, EFNB2, EFNB3, and TrkA transcripts compared to nonamplified tumors (P = 0.0006, P = 0.0023, P = 0.0048, and P = 0.0001, respectively).","tracks":[{"project":"sentences","denotations":[{"id":"TextSentencer_T9","span":{"begin":0,"end":189},"obj":"Sentence"},{"id":"T9","span":{"begin":0,"end":189},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T9","pred":"source","obj":"sentences"},{"subj":"T9","pred":"source","obj":"sentences"}]},{"project":"PubmedHPO","denotations":[{"id":"T6","span":{"begin":15,"end":21},"obj":"HP_0002664"},{"id":"T7","span":{"begin":115,"end":121},"obj":"HP_0002664"}],"attributes":[{"subj":"T6","pred":"source","obj":"PubmedHPO"},{"subj":"T7","pred":"source","obj":"PubmedHPO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"sentences","color":"#b9ec93","default":true},{"id":"PubmedHPO","color":"#ec93d3"}]}]}}